Anti-Carboxypeptidase-X2 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting the propeptide domain of human Carboxypeptidase-X2 (CPXM2), validated for Western blot applications.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q8N436
Size
100ug
Cat. #
RP3CarboxypeptidaseX2

In stock

SKU
RP-CarboxypeptidaseX2

Options

As low as: $130.00

Target Overview

Carboxypeptidase-X2 (CPXM2, UniProt Q8N436), also known as inactive carboxypeptidase-like protein X2, is a 756-residue secreted protein belonging to the metallocarboxypeptidase family. Despite its structural homology to catalytically active carboxypeptidases, CPXM2 lacks enzymatic activity due to amino acid substitutions in the zinc-binding motif critical for catalysis. The protein is predicted to function in cell-cell interactions rather than proteolysis, distinguishing it from classical carboxypeptidases that remove C-terminal amino acids from peptide substrates. CPXM2 is expressed as a secreted glycoprotein and has been detected in various tissue types, with emerging evidence suggesting tissue-specific regulatory roles. Researchers study CPXM2 in contexts ranging from cardiovascular biology to oncology, where its expression patterns correlate with disease progression and patient outcomes. The protein's propeptide domain, which serves as the immunogen for Triple Point Biologics' three polyclonal antibodies, represents a conserved region suitable for detection across experimental models and sample types.

Background

CPXM2 has garnered attention in recent years as a candidate biomarker and potential functional contributor in multiple pathological contexts. Zhou et al. (2026) analyzed CPXM2 expression alongside FAP and Caveolin1 in gastric cancer, identifying prognostic significance that suggests a role in tumor microenvironment remodeling or stromal signaling. In cardiovascular research, CPXM2 has been implicated in left ventricular hypertrophy, with Subrova et al. (2022) demonstrating that miRNA-29b and miRNA-497 modulate CPXM2 expression, positioning the gene within post-transcriptional regulatory networks relevant to cardiac remodeling. Proteomic profiling studies have detected CPXM2 in diverse biological fluids and tissue contexts, including cerebrospinal fluid extracellular vesicles from pediatric pilocytic astrocytoma and preserved formalin-fixed paraffin-embedded specimens from infantile hypertrophic pyloric stenosis, underscoring its broad tissue distribution and potential utility as a disease-associated marker. The functional role of CPXM2 remains incompletely defined. Its classification as an inactive carboxypeptidase suggests evolutionary repurposing from an ancestral catalytic enzyme to a structural or regulatory protein. The secreted localization and predicted involvement in cell-cell interactions hint at extracellular matrix association or receptor-mediated signaling, though direct binding partners and downstream effectors have not been comprehensively characterized. Triple Point Biologics offers three rabbit polyclonal antibodies raised against the propeptide domain, providing researchers with validated reagents for Western blot, immunohistochemistry, and immunofluorescence detection of endogenous CPXM2 in human samples. These tools support ongoing investigations into CPXM2 biology across oncology, cardiovascular disease, and developmental pathology.

References

  1. Zhou L et al (2026) Analysis of the expression of FAP, Caveolin1, and CPXM2 and prognostic significance in gastric cancer. Front Oncol. PubMed · 10.3389/fonc.2026.1716536
  2. Sun W et al (2025) Revealing Causal Protein Biomarkers and Potential Therapeutic Targets for Histologic-Specific Lung Cancer. J Cell Mol Med. PubMed · 10.1111/jcmm.70866
  3. Shinohara M et al (2025) Proteome analysis of preserved formalin-fixed and paraffin-embedded specimens to explore the pathogenesis of infantile hypertrophic pyloric stenosis. Pediatr Surg Int. PubMed · 10.1007/s00383-025-06153-0
  4. Spinelli S et al (2024) Proteomic Profiling of Cerebrospinal Fluid and Its Extracellular Vesicles from Extraventricular Drainage in Pediatric Pilocytic Astrocytoma, towards Precision Oncology. Cancers (Basel). PubMed · 10.3390/cancers16061223
  5. Subrova J et al (2022) MiRNA-29b and miRNA-497 Modulate the Expression of Carboxypeptidase X Member 2, a Candidate Gene Associated with Left Ventricular Hypertrophy. Int J Mol Sci. PubMed · 10.3390/ijms23042263

Additional Specifications

Gene Symbol CPXM2
UniProt ID Q8N436
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 26-65.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 317-640.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 706-756.
Alternate Names CPXM2, Inactive carboxypeptidase-like protein X2, Carboxypeptidase X member 2

Frequently Asked Questions

What molecular weight should I expect for CPXM2 on Western blot?

CPXM2 (Q8N436) has a predicted molecular weight of approximately 84 kDa based on its 756-residue sequence. However, because CPXM2 is a secreted glycoprotein, the apparent molecular weight on Western blot typically runs higher, often in the 90-110 kDa range depending on glycosylation state and tissue source. If you are analyzing conditioned media or serum samples, expect the fully glycosylated form. Deglycosylation with PNGase F prior to SDS-PAGE can confirm glycosylation contributions if you observe multiple bands or higher-than-predicted migration.

Does this antibody distinguish CPXM2 from other carboxypeptidase family members?

This polyclonal antibody is raised against human CPXM2 and validated for specificity against CPXM2. Given the structural homology within the metallocarboxypeptidase family, we recommend including lysates or tissues known to express related family members such as CPXM1 or classical carboxypeptidases as specificity controls. Sequence alignment shows CPXM2 has divergent regions outside the zinc-binding motif, but empirical testing with knockout or knockdown lysates provides the most definitive specificity confirmation for your experimental system. Predicted cross-reactivity with other family members has not been systematically evaluated.

What is the recommended starting dilution for Western blot with this CPXM2 antibody?

The validated dilution for Western blot is 1:1000 in blocking buffer, typically 5% non-fat milk or 3% BSA in TBST. This dilution has been optimized for detecting endogenous CPXM2 in human lysates. Start at 1:1000 and titre if needed based on signal strength and background in your specific sample type. Overnight incubation at 4°C often improves sensitivity for low-abundance targets compared to 1-hour room temperature incubation. Loading 20-40 µg total protein per lane is a reasonable starting point for tissues with moderate CPXM2 expression.

Can I use this antibody for mouse or rat samples?

This antibody is validated for human CPXM2. Cross-reactivity with mouse or rat CPXM2 is predicted based on sequence homology but has not been experimentally validated. Human and mouse CPXM2 share approximately 75-80% sequence identity. If you plan to use this antibody with mouse or rat samples, we recommend testing it alongside a positive human control and confirming the expected molecular weight. Empirical validation with known CPXM2-expressing mouse tissues or cell lines is necessary before drawing conclusions from negative or unexpected results.

Why does CPXM2 lack carboxypeptidase activity despite being in that family?

CPXM2 contains amino acid substitutions in the zinc-binding motif that is essential for metallocarboxypeptidase catalytic activity. Classical carboxypeptidases coordinate zinc via conserved histidine and glutamate residues to hydrolyze C-terminal peptide bonds, but CPXM2 has lost these critical catalytic residues through evolution. Current evidence suggests CPXM2 functions in cell-cell interactions or signaling rather than proteolysis. When interpreting experimental results, researchers should consider CPXM2 as a regulatory or structural protein, not an enzyme. This distinction is important for functional assays and pathway analysis.

What positive control tissue or cell line should I use for CPXM2 Western blot?

CPXM2 expression is tissue-specific, with detection reported in cardiovascular tissues and other contexts, though comprehensive expression atlases are still emerging. For a positive control, consider using human cell lines or tissues where CPXM2 expression has been documented in transcriptomic databases such as GTEx or Human Protein Atlas. Conditioned media from secreting cell lines may provide stronger signal than whole-cell lysates since CPXM2 is a secreted protein. If you are working with a novel tissue or cell type, running a known CPXM2-expressing sample in parallel will help confirm antibody performance.

Can this antibody be used for immunohistochemistry or immunofluorescence?

Triple Point Biologics antibodies are validated for Western blot and generally suitable for IHC and immunofluorescence applications, though specific validation for this CPXM2 antibody in IHC has been performed. For IHC, antigen retrieval is typically required; citrate buffer (pH 6.0) heat-induced epitope retrieval is a reasonable starting method. Because CPXM2 is secreted, expect extracellular or pericellular staining patterns rather than intracellular localization in most tissues. Optimal dilutions for IHC are typically 5-10 times more concentrated than Western blot dilutions; start around 1:100 to 1:200 and optimize.

How should I store this antibody and what is the expected shelf life?

Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce antibody activity over time. The antibody is supplied at 100 µg in a glycerol-containing buffer that remains liquid at -20°C, allowing direct pipetting without thawing if stored properly. For long-term storage beyond one year, -80°C is preferable. Once thawed, aliquots can be stored at 4°C for up to one month with sodium azide preservative. Avoid storing diluted antibody; prepare working dilutions fresh for each experiment to maintain optimal performance.

Validation imagery coming soon

Western blot validation figures for RP-CarboxypeptidaseX2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • CPXM2
  • Inactive carboxypeptidase-like protein X2
  • Carboxypeptidase X member 2
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →